Sarah Ackroyd

565 total citations
23 papers, 336 citations indexed

About

Sarah Ackroyd is a scholar working on Oncology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Sarah Ackroyd has authored 23 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Obstetrics and Gynecology and 5 papers in Reproductive Medicine. Recurrent topics in Sarah Ackroyd's work include Endometrial and Cervical Cancer Treatments (5 papers), Ovarian cancer diagnosis and treatment (4 papers) and Cancer survivorship and care (4 papers). Sarah Ackroyd is often cited by papers focused on Endometrial and Cervical Cancer Treatments (5 papers), Ovarian cancer diagnosis and treatment (4 papers) and Cancer survivorship and care (4 papers). Sarah Ackroyd collaborates with scholars based in United States, United Kingdom and Canada. Sarah Ackroyd's co-authors include Deborah J. Wexler, Seth A. Berkowitz, Hilary K. Seligman, Giselle Corbie‐Smith, Steven J. Atlas, Andrew J. Karter, Nita K. Lee, Paul Harper, Elbert S. Huang and Katherine C. Kurnit and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Diabetes Care.

In The Last Decade

Sarah Ackroyd

21 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Ackroyd United States 9 105 88 55 53 53 23 336
Virginia Signal New Zealand 11 80 0.8× 63 0.7× 56 1.0× 117 2.2× 47 0.9× 23 369
Ruying Hu China 14 37 0.4× 170 1.9× 34 0.6× 69 1.3× 22 0.4× 37 600
María Carmen Muñoz-Villanueva Spain 13 38 0.4× 55 0.6× 17 0.3× 143 2.7× 110 2.1× 30 419
Su-Fen Qi China 12 21 0.2× 71 0.8× 39 0.7× 27 0.5× 37 0.7× 20 315
Linda J. Hazlett United States 12 28 0.3× 200 2.3× 55 1.0× 19 0.4× 17 0.3× 18 432
A-M Ugnat Canada 6 36 0.3× 88 1.0× 108 2.0× 60 1.1× 19 0.4× 7 385
Cátia Millene Dell Agnolo Brazil 12 78 0.7× 145 1.6× 107 1.9× 72 1.4× 4 0.1× 44 461
Shilpi S. Mehta‐Lee United States 13 27 0.3× 110 1.3× 16 0.3× 90 1.7× 26 0.5× 46 476
Mehdi Aloosh Canada 12 37 0.4× 33 0.4× 23 0.4× 48 0.9× 37 0.7× 32 365
Azam Majidi Iran 10 40 0.4× 39 0.4× 82 1.5× 55 1.0× 20 0.4× 15 402

Countries citing papers authored by Sarah Ackroyd

Since Specialization
Citations

This map shows the geographic impact of Sarah Ackroyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Ackroyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Ackroyd more than expected).

Fields of papers citing papers by Sarah Ackroyd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Ackroyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Ackroyd. The network helps show where Sarah Ackroyd may publish in the future.

Co-authorship network of co-authors of Sarah Ackroyd

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Ackroyd. A scholar is included among the top collaborators of Sarah Ackroyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Ackroyd. Sarah Ackroyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weigert, Melanie, Yan Li, Heather Eckart, et al.. (2025). A cell atlas of the human fallopian tube throughout the menstrual cycle and menopause. Nature Communications. 16(1). 372–372. 4 indexed citations
2.
3.
Spees, Lisa P., et al.. (2024). Geographic and racial disparities in the quality of surgical care among patients with nonmetastatic uterine cancer. American Journal of Obstetrics and Gynecology. 232(3). 308.e1–308.e15. 1 indexed citations
4.
Ackroyd, Sarah, et al.. (2024). The burden of cervical cancer survivorship: Understanding morbidity and survivorship needs through hospital admissions. Gynecologic Oncology Reports. 51. 101328–101328. 2 indexed citations
5.
Lengyel, Ernst, Yan Li, Melanie Weigert, et al.. (2022). A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing. Cell Reports. 41(12). 111838–111838. 29 indexed citations
6.
Ackroyd, Sarah, et al.. (2022). Lessons learned: Telemedicine patterns and clinical application in patients with gynecologic cancers during COVID-19. Gynecologic Oncology Reports. 41. 100986–100986. 4 indexed citations
7.
Ackroyd, Sarah, et al.. (2022). Surviving and thriving: What do survivors of gynecologic cancer want?. Gynecologic Oncology Reports. 41. 101011–101011. 8 indexed citations
8.
Ackroyd, Sarah, David Arguello, Pilar Ramos, et al.. (2022). Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma. Gynecologic Oncology. 169. 164–171. 6 indexed citations
9.
Ackroyd, Sarah, Elbert S. Huang, Katherine C. Kurnit, & Nita K. Lee. (2021). Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis. Gynecologic Oncology. 162(2). 249–255. 24 indexed citations
10.
Ackroyd, Sarah, et al.. (2021). A look at the gynecologic oncologist workforce – Are we meeting patient demand?. Gynecologic Oncology. 163(2). 229–236. 20 indexed citations
11.
Ackroyd, Sarah, et al.. (2021). Telemedicine utilization in gynecologic cancers: understanding the digital divide. Gynecologic Oncology. 162. S286–S287. 1 indexed citations
12.
Ackroyd, Sarah, et al.. (2020). Postoperative complications of epidural analgesia at hysterectomy for gynecologic malignancies: an analysis of the National Surgical Quality Improvement Program. International Journal of Gynecological Cancer. 30(8). 1203–1209. 6 indexed citations
13.
14.
Ackroyd, Sarah, et al.. (2019). Pancreaticobiliary metastasis presenting as primary mucinous ovarian neoplasm: A systematic literature review. Gynecologic Oncology Reports. 28. 109–115. 4 indexed citations
15.
Ackroyd, Sarah, et al.. (2019). Residents at Inner-City Academic Centers May Fail to Meet the New Minimally Invasive Hysterectomy Requirements [14P]. Obstetrics and Gynecology. 133(1). 174–174. 1 indexed citations
16.
Ackroyd, Sarah, et al.. (2018). A preoperative risk score to predict red blood cell transfusion in patients undergoing hysterectomy for ovarian cancer. American Journal of Obstetrics and Gynecology. 219(6). 598.e1–598.e10. 13 indexed citations
17.
Ackroyd, Sarah, et al.. (2017). Interval robotic cytoreduction following neoadjuvant chemotherapy in advanced ovarian cancer. Journal of Robotic Surgery. 12(2). 245–250. 19 indexed citations
18.
Ackroyd, Sarah & Deborah J. Wexler. (2014). Effectiveness of Diabetes Interventions in the Patient-Centered Medical Home. Current Diabetes Reports. 14(3). 471–471. 31 indexed citations
19.
Allman, Erik L., et al.. (2013). Analysis of Ca2+ Signaling Motifs That Regulate Proton Signaling through the Na+/H+ Exchanger NHX-7 during a Rhythmic Behavior in Caenorhabditis elegans*. Journal of Biological Chemistry. 288(8). 5886–5895. 8 indexed citations
20.
Harper, Paul, et al.. (1990). Do we pay too dearly for our sport and leisure activities?. Public Health. 104(6). 417–423. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginia Signal Breakdown of academic impact, for papers by Ruying Hu Breakdown of academic impact, for papers by María Carmen Muñoz-Villanueva Breakdown of academic impact, for papers by Su-Fen Qi Breakdown of academic impact, for papers by Linda J. Hazlett Breakdown of academic impact, for papers by A-M Ugnat Breakdown of academic impact, for papers by Cátia Millene Dell Agnolo Breakdown of academic impact, for papers by Shilpi S. Mehta‐Lee Breakdown of academic impact, for papers by Mehdi Aloosh Breakdown of academic impact, for papers by Azam Majidi
Rankless by CCL
2026